Recruiting PHASE4 INTERVENTIONAL 2-arm NCT05898087

Subpectoral Bupivacaine for Pain Management in Adolescent Reduction Mammaplasty

Sponsor: Connecticut Children's Medical Center

Conditions Macromastia Post-operative Pain

Interventions Marcaine 0.25 % Injectable Solution Saline

Updated 5 times since 2023 Last updated: May 23, 2025 Started: Apr 1, 2022 Primary completion: Apr 1, 2026 Completion: Apr 1, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Macromastia and Post-operative Pain and is currently actively recruiting participants. Connecticut Children's Medical Center leads this study, which shows 5 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Jun 2025 — Present [monthly]

Recruiting PHASE4
Oct 2024 — Jun 2025 [monthly]

Recruiting PHASE4
Sep 2024 — Oct 2024 [monthly]

Recruiting PHASE4
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE4
Jul 2023 — Jul 2024 [monthly]

Recruiting PHASE4

First recorded

Apr 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Connecticut Children's Medical Center

Data source: Connecticut Children's Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Farmington, United States
• Hartford, United States